Roche : FDA Grants Breakthrough Device Designation To Elecsys GDF-15 Assay

(RTTNews) – The U.S. Food and Drug Administration has granted breakthrough device designation for Roche’s (RHHBY) Elecsys growth differentiation factor-15 or GDF-15 assay to help identify patients suitable for treatment addressing unintentional weight loss in cancer patients, RocRead MoreMarketsMarkets Feed